Search

everythinglearnresearchcommunity

for

Search:↓

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Finasteride is more effective and satisfactory than montelukast for treating moderate acne in women.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

No strong link between testosterone or DHEAS levels and acne or hair loss in females.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Hormonal status significantly affects women's skin health throughout their lives.

Women with hyperandrogenism, especially those with PCOS, are more likely to have psychiatric disorders.

Early diagnosis and treatment of PCOS can prevent complications and improve symptoms.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Stress greatly reduces the quality of life in women with PCOS-related infertility.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Obese and lean women with PCOS have different symptoms and need different treatments.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Testosterone therapy can safely and effectively treat symptoms like low libido and fatigue in women, especially after menopause.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

PCOS significantly harms married women's quality of life, affecting mental health, fertility, and body image.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.